BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Metabolism of xenobiotics, Influenza, Heart, Anticancer prodrugs, Trichostatin A)
Bookmark Forward

QuickView for benign prostatic hyperplasia (phenotype)


Genetic Markers

Most Correlated Genes

Most Correlated SNPs

  1. CXCL13
  2. TGM4
  3. BMP5
  4. NR4A2
  5. CLSTN2
  1. No SNPs found
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. LIU_PROSTATE_CANCER_DN
  2. SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
  3. CHEN_METABOLIC_SYNDROM_NETWORK
  4. MODULE_84
  5. RODWELL_AGING_KIDNEY_UP
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Benign prostatic hyperplasia BPH-1 cells with COX2 shRNA knockdown
  2. Effects of GSTM1 state and consuming glucosinolate from broccoli on prostate of PIN patients
  3. Human body index - transcriptional profiling
  4. Fine-needle aspiration biopsies of prostate cancers and benign prostatic hyperplasias
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. LUTS/BPH increases the risk of depressive symptoms among elderly adults: A 5-year longitudinal evide…
  2. Impact of kidney disease on perioperative outcomes of endoscopic BPH surgery: a propensity score mat…
  3. Cluster nursing care based on 10S continuous quality improvement reduces incidence of postoperative …
  4. The use of drug vitaprost forte in patients with benign prostate hyperplasia].
  5. Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study in Benign Prostatic Hyperplasia
  2. Prostate Embolization for Benign Prostatic Hyperplasia
  3. Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
  4. A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
  5. The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.